SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000912057-20-000157
Filing Date
2020-05-13
Accepted
2020-05-13 17:18:34
Documents
20

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2485449
2 g52075.jpg GRAPHIC 35182
3 g67368.jpg GRAPHIC 20919
4 g128640.jpg GRAPHIC 30383
5 g164461.jpg GRAPHIC 11131
6 g231995.jpg GRAPHIC 40572
7 g303045.jpg GRAPHIC 71183
8 g316093.jpg GRAPHIC 47549
9 g412503.jpg GRAPHIC 65824
10 g421438.jpg GRAPHIC 23140
11 g581536.jpg GRAPHIC 74164
12 g621163.jpg GRAPHIC 159440
13 g708735.jpg GRAPHIC 18418
14 g866638.jpg GRAPHIC 35303
15 g926108.jpg GRAPHIC 53460
16 g938891.jpg GRAPHIC 47524
17 g940207.jpg GRAPHIC 85510
18 g976574.jpg GRAPHIC 52522
19 g982218.jpg GRAPHIC 22604
20 g1009631.jpg GRAPHIC 17570
  Complete submission text file 0000912057-20-000157.txt   3745373
Mailing Address 456 MONTGOMERY STREET SUITE 1200 SAN FRANCISCO CA 94104
Business Address 456 MONTGOMERY STREET SUITE 1200 SAN FRANCISCO CA 94104 (415) 655-4899
Angion Biomedica Corp. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-03054 | Film No.: 20874219
SIC: 2834 Pharmaceutical Preparations